Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) is scheduled to release its 12/31/2023 earnings data before the market opens on Wednesday, February 21st. Analysts expect Calliditas Therapeutics AB (publ) to post earnings of ($0.09) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do […]
Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $25.00, but opened at $24.01. Calliditas Therapeutics AB (publ) shares last traded at $23.85, with a volume of 4,324 shares traded. Wall Street Analyst Weigh In Separately, HC Wainwright reiterated […]
Calliditas Therapeutics AB’s American depositary receipts jumped 15% premarket on Thursday after the company said late Wednesday that its kidney treatment.
Micron forecast fiscal second-quarter revenue higher than expectations, the CEOs of Warner Bros. Discovery and Paramount Global discussed a possible merger,.
HC Wainwright reaffirmed their buy rating on shares of Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Free Report) in a research note published on Monday, Benzinga reports. They currently have a $50.00 price target on the stock. Separately, Guggenheim lowered their price target on shares of Calliditas Therapeutics AB (publ) from $21.00 to $18.00 and set […]